MCP
CVS icon

Mirador Capital Partners’s CVS Health CVS Stock Holding History

Mirador Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,599
Closed -$429K – 194
2022
Q4 		$429K Buy
4,599
+32
+0.7% +$3.09K 0.1% 124
2022
Q3 		$436K Sell
4,567
-105
-2% -$10.4K 0.11% 125
2022
Q2 		$433K Sell
4,672
-303
-6% -$29.6K 0.1% 129
2022
Q1 		$504K Buy
4,975
+100
+2% +$10.5K 0.1% 139
2021
Q4 		$503K Buy
4,875
+82
+2% +$7.58K 0.11% 143
2021
Q3 		$407K Sell
4,793
-100
-2% -$8.38K 0.09% 152
2021
Q2 		$408K Buy
4,893
+200
+4% +$16.4K 0.09% 151
2021
Q1 		$353K Sell
4,693
-222
-5% -$16.2K 0.09% 138
2020
Q4 		$336K Buy
4,915
+104
+2% +$6.76K 0.09% 140
2020
Q3 		$281K Buy
4,811
+383
+9% +$23.8K 0.09% 143
2020
Q2 		$288K Buy
4,428
+390
+10% +$24.6K 0.11% 124
2020
Q1 		$244K Sell
4,038
-670
-14% -$44.7K 0.1% 121
2019
Q4 		$350K Buy
4,708
+47
+1% +$3.3K 0.14% 131
2019
Q3 		$294K Buy
4,661
+100
+2% +$5.93K 0.13% 140
2019
Q2 		$249K Buy
4,561
+547
+14% +$29.5K 0.12% 133
2019
Q1 		$216K Buy
4,014
+4
+0.1% +$247 0.12% 135
2018
Q4 		$263K Hold
4,010
– – 0.16% 108
2018
Q3 		$316K Hold
4,010
– – 0.15% 113
2018
Q2 		$258K Sell
4,010
-1,381
-26% -$91K 0.14% 116
2018
Q1 		$376K Buy
5,391
+174
+3% +$12.5K 0.26% 81
2017
Q4 		$378K Buy
5,217
+19
+0.4% +$1.38K 0.21% 92
2017
Q3 		$420K Hold
5,198
– – 0.25% 83
2017
Q2 		$405K Buy
5,198
+1,198
+30% +$94.6K 0.25% 85
2017
Q1 		$314K Buy
+4,000
New +$319K 0.23% 93

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Mirador Capital Partners's CVS Position: Q1 2023 in Review

Mirador Capital Partners sold out of CVS Health (CVS) in Q1 2023, closing a stake of 4,599 shares — an estimated $429K sold.

Mirador Capital Partners first reported a position in CVS in Q1 2017 and held it in 24 quarters. The position peaked at $504K in Q1 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Mirador Capital Partners reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Mirador Capital Partners sold 4,599 CVS Health shares in Q1 2023, an estimated $429K.
  • Mirador Capital Partners first reported a position in CVS Health in Q1 2017 and held it in 24 quarters.
  • Mirador Capital Partners's CVS Health position peaked at $504K in Q1 2022.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Mirador Capital Partners's 13F filing for Q1 2023, filed 14 Apr 2023.